RemSleep Holdings (RMSL) Cash from Investing Activities (QoQ) (2015 - 2023)
RemSleep Holdings (RMSL) Cash from Investing Activities (QoQ) (2015 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -55.54% |
| Mar 31, 2023 | -152.85% |
| Jun 30, 2022 | -86.94% |
| Mar 31, 2022 | 13.55% |
| Dec 31, 2021 | -39.36% |
| Sep 30, 2021 | -30,298.53% |
| Jun 30, 2021 | 99.62% |
| Mar 31, 2021 | -7,768.89% |
| Dec 31, 2020 | 97.35% |
| Sep 30, 2020 | 58.61% |
| Jun 30, 2020 | -173.33% |
| Mar 31, 2020 | 82.37% |
| Dec 31, 2019 | -55.24% |
| Sep 30, 2019 | -1,024.50% |
| Jun 30, 2019 | 90.05% |
| Mar 31, 2019 | -44.37% |
| Dec 31, 2018 | 10.32% |
| Sep 30, 2018 | -184.52% |
| Sep 30, 2017 | 200.00% |
| Mar 31, 2016 | 300,100.00% |